|View printer-friendly version|
|September 12, 2002 4:20 p.m.|
|Teva Announces Final Approval of Nizatidine Capsules|
Jerusalem, Israel, September 12, 2002 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U. S. Food and Drug Administration has approved the company's ANDA for Nizatidine Capsules USP, 150 mg and 300 mg. Shipment of this product is expected to begin immediately.